FDA Says Diabetes Drug Onglyza May be Linked to Higher Death Rate
After conducting a preliminary review of data, the U.S. Food and Drug Administration (FDA) has issued a report indicating that AstraZeneca’s diabetes drug Onglyza may be linked with an increased [...]